Cover Image

Treatment of rapidly progressive IgA nephropathy with glucocorticoid plus telitacicept: one case report

Saved in:

Bibliographic Details
Main Authors:	Jia-xin Huang (Author), Jin Liu (Author), Yi Fang (Author), Wei-chun He (Author)
Format:	Book
Published:	Editorial Department of Journal of Clinical Nephrology, 2024-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Successful pregnancy in a patient with IgA nephropathy treated with telitacicept: a case report
by: Xinru Du, et al.
Published: (2024)

Glucocorticoids Reduce Aberrant O-Glycosylation of IgA1 in IgA Nephropathy Patients
by: Petr Kosztyu, et al.
Published: (2018)

Research advances Progress in the pathogenesis of IgA nephropathy
by: Fei-fei Wang, et al.
Published: (2024)

Efficacy and safety of tacrolimus-based treatment for non-rapidly progressive IgA nephropathy
by: Lijuan Zhao, et al.
Published: (2023)

Blood and urine biomarkers of disease progression in IgA nephropathy
by: Zhi-Yu Duan, et al.
Published: (2024)

Role of abnormal glycosylated IgA1 and interstitial transformation of glomerular endothelial cells in the development and progression of IgA nephropathy
by: Wanyu Jia, et al.
Published: (2023)

Sulodexide in IgA nephropathy
Published: (2013)

Clinicopathological Characteristics, Role of Immunosuppressive Therapy and Progression in IgA Nephropathy with Hyperuricemia
by: Yiping Ruan, et al.
Published: (2018)

Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria
by: Ding Chen, et al.
Published: (2018)

Plasma ST6GAL1 regulates IgG sialylation to control IgA nephropathy progression
by: Youxia Liu, et al.
Published: (2021)

The Clinical Significance of Uric Acid and Complement Activation in the Progression of IgA Nephropathy
by: Yasar Caliskan, et al.
Published: (2016)

Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy
by: Kai Zhang, et al.
Published: (2019)

The effectiveness and safety of full-dose half-dose corticosteroid plus renin-angiotensin system blockers for IgA nephropathy
by: Li Wang, et al.
Published: (2019)

An Update on Targeted Treatment of IgA Nephropathy: An Autoimmune Perspective
by: Xin Huang, et al.
Published: (2021)

Role of Human Mesangial-Tubular Crosstalk in Secretory IgA-Induced IgA Nephropathy
by: Junjun Zhang, et al.
Published: (2021)

Management of IgA Nephropathy in Pediatric Patients
by: Sophie Schroda, et al.
Published: (2022)

Clinical significance of IgA nephropathy with hyperuricemia
by: Han Zhou, et al.
Published: (2024)

Horseshoe kidney with concurrent mesangial proliferative IgA nephropathy：one case report
by: Huang Tan, et al.
Published: (2024)

Treatment and outcome of IgA nephropathy in children from one single center experience
by: Youying Mao, et al.
Published: (2023)

Serum Phosphorus Might Be a Predictor of Kidney Disease Progression in IgA Nephropathy
by: Huixian Li, et al.
Published: (2023)

Comparative study on clinicopathological features and prognosis of IgA vasculitis nephritis and IgA nephropathy in children
by: Yan Lv, et al.
Published: (2023)

IgA nephropathy combined with thin basement membrane nephropathy in children
Published: (2013)

Beneficial effects of tonsillectomy plus steroid pulse therapy on inflammatory and tubular markers in patients with IgA nephropathy
by: Shuntaro Maruyama, et al.
Published: (2016)

Therapeutic Effects of FK506 on IgA Nephropathy Rat
by: Linting Wei, et al.
Published: (2017)

New Insights into the Pathogenesis and Therapies of IgA Nephropathy
Published: (2022)

The case of nutcracker phenomenon associated with IgA nephropathy
by: Medin Danilo V., et al.
Published: (2021)

Diagnosis and treatment of patients with IgA nephropathy in Japan
by: Yasuhiko Tomino
Published: (2016)

Correlation between serum Klotho and uromodulin expression levels and IgA nephropathy complicated with hyperuricemia
by: Di Wei, et al.
Published: (2024)

Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy
by: Koshi Yamada, et al.
Published: (2020)

Clinicopathological Features and Outcomes of IgA Nephropathy with Hematuria and/or Minimal Proteinuria
by: Min Tan, et al.
Published: (2015)

Prognosis of IgA Nephropathy with Stages 3b-5 CKD
by: Zhanfei Wu, et al.
Published: (2024)

Clinicopathologic characteristics and outcomes of IgA nephropathy patients with different proportions of crescent
by: Chun-hua Liu, et al.
Published: (2024)

Successful treatment of IgA nephropathy complicated by ankylosing spondylitis with recurrent anterior uveitis with adalimumab: one case report
by: Jia-biao Wu, et al.
Published: (2024)

Concurrent Anti-glomerular Basement Membrane Nephritis and IgA Nephropathy
by: Kwang-Sun Suh, et al.
Published: (2019)

Chylopericardium in a child with IgA nephropathy: a case report
by: Yu-lin Kang, et al.
Published: (2018)

Corticosteroid therapy in IgA Nephropathy: A friend or foe?
by: Dana Kim, et al.
Published: (2023)

Exacerbation of IgA nephropathy in a patient receiving dupilumab
by: Masako Yamamoto, MD, et al.
Published: (2022)

Immune Characteristics of IgA Nephropathy With Minimal Change Disease
by: Huixian Li, et al.
Published: (2021)

Proceedings of 16th International Symposium on IgA Nephropathy
Published: (2021)

The Clinical Significance and Potential Role of Cathepsin S in IgA Nephropathy
by: Jingying Zhao, et al.
Published: (2021)